https://novapharmanews.com/us/news/eli-lilly-acquires-vaccine-developers-38b 2026-05-28T12:35:17.777Z NovaPharmaNews en-US 2026-05-28T09:32:01.397Z Eli Lilly Acquires 3 Vaccine Developers in $3.8B Deal https://novapharmanews.com/uploads/articles/eli-lilly-acquires-vaccine-developers-38b.webp Eli Lilly Acquires 3 Vaccine Developers in $3.8B Deal https://novapharmanews.com/us/news/lilly-gilead-pharma-ma-boom-market-analysis 2026-05-28T12:35:25.120Z NovaPharmaNews en-US 2026-05-28T09:32:01.397Z Lilly and Gilead Lead Pharma's M&A Boom: Market Analysis https://novapharmanews.com/uploads/articles/lilly-gilead-pharma-ma-boom-market-analysis.webp Lilly and Gilead Lead Pharma's M&A Boom: Market Analysis https://novapharmanews.com/apac/news/hanmi-pharma-organon-partnership-southeast-asia 2026-05-28T12:35:27.556Z NovaPharmaNews en-AU 2026-05-28T09:32:01.397Z Hanmi Pharma and Organon: Strategic Partnership for Southeast Asia https://novapharmanews.com/uploads/articles/hanmi-pharma-organon-partnership-southeast-asia.webp Hanmi Pharma and Organon: Strategic Partnership for Southeast Asia https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-05-28T10:31:10.807Z NovaPharmaNews en-AU 2026-05-28T09:32:01.397Z Regulatory Round-Up: Drug Approvals on 18 May 2026 https://novapharmanews.com/uploads/articles/regulatory-round-up-drug-approvals-18-may-2026.webp Regulatory Round-Up: Drug Approvals on 18 May 2026 https://novapharmanews.com/eu/news/european-critical-medicines-act-market-analysis 2026-05-28T12:11:49.689Z NovaPharmaNews en-GB 2026-05-28T09:32:01.397Z European Critical Medicines Act: Market Analysis and Implications https://novapharmanews.com/uploads/articles/european-critical-medicines-act-market-analysis.webp European Critical Medicines Act: Market Analysis and Implications https://novapharmanews.com/eu/news/ai-accelerates-novo-nordisk-parkinsons-cell-therapy 2026-05-28T12:03:33.322Z NovaPharmaNews en-GB 2026-05-28T09:32:01.397Z AI Accelerates Novo Nordisk's Parkinson’s Cell Therapy cell therapy, Parkinson’s disease https://novapharmanews.com/uploads/articles/ai-accelerates-novo-nordisk-parkinsons-cell-therapy.webp AI Accelerates Novo Nordisk's Parkinson’s Cell Therapy https://novapharmanews.com/us/news/3-overlooked-stocks-soar-2026-clinical-trials 2026-05-28T12:35:15.344Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z 3 Overlooked Stocks Set to Soar in 2026 — Clinical Trials https://novapharmanews.com/uploads/articles/3-overlooked-stocks-soar-2026-clinical-trials.webp 3 Overlooked Stocks Set to Soar in 2026 — Clinical Trials https://novapharmanews.com/us/news/fda-guidelines-generic-bioequivalence-oncology 2026-05-28T12:35:20.257Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z FDA Guidelines Enhance Generic Bioequivalence in Oncology Drugs oncology https://novapharmanews.com/uploads/articles/fda-guidelines-generic-bioequivalence-oncology.webp FDA Guidelines Enhance Generic Bioequivalence in Oncology Drugs https://novapharmanews.com/us/news/lifesaving-upgrades-fda-oncology-approvals 2026-05-28T12:37:44.945Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z Lifesaving Upgrades: 40 Years of FDA Oncology Approvals oncology https://novapharmanews.com/uploads/articles/lifesaving-upgrades-fda-oncology-approvals.webp Lifesaving Upgrades: 40 Years of FDA Oncology Approvals https://novapharmanews.com/us/news/top-10-anticipated-drug-launches-2026 2026-05-28T12:11:10.317Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z Top 10 Most Anticipated Drug Launches of 2026 https://novapharmanews.com/uploads/articles/top-10-anticipated-drug-launches-2026.webp Top 10 Most Anticipated Drug Launches of 2026 https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-05-28T14:47:22.792Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z AstraZeneca and Daiichi's New Drug Approved for Breast Cancer breast cancer https://novapharmanews.com/uploads/articles/astrazeneca-daiichi-drug-approval-breast-cancer.webp AstraZeneca and Daiichi's New Drug Approved for Breast Cancer https://novapharmanews.com/us/news/neurosense-regulatory-advancements-alzheimers-trials 2026-05-28T12:11:58.063Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z NeuroSense's Regulatory Advancements in Alzheimer's Trials Alzheimer's disease https://novapharmanews.com/uploads/articles/neurosense-regulatory-advancements-alzheimers-trials.webp NeuroSense's Regulatory Advancements in Alzheimer's Trials https://novapharmanews.com/us/news/inventiva-leadership-lanifibranor-phase-3-data 2026-05-28T12:12:13.685Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z Inventiva Strengthens Leadership Team Ahead of Lanifibranor Phase 3 Data Lanifibranor https://novapharmanews.com/uploads/articles/inventiva-leadership-lanifibranor-phase-3-data.webp Inventiva Strengthens Leadership Team Ahead of Lanifibranor Phase 3 Data https://novapharmanews.com/us/news/fda-restricts-compounding-weight-loss-drugs 2026-05-28T12:35:22.689Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z FDA Restricts Large-Scale Compounding of Weight Loss Drugs weight loss https://novapharmanews.com/uploads/articles/fda-restricts-compounding-weight-loss-drugs.webp FDA Restricts Large-Scale Compounding of Weight Loss Drugs https://novapharmanews.com/us/news/fda-decisions-q2-2026-drug-approvals 2026-05-28T12:11:04.082Z NovaPharmaNews en-US 2026-05-28T09:31:55.221Z 5 FDA Drug Approvals to Watch in 2026 https://novapharmanews.com/uploads/articles/fda-drug-approvals-2026.webp 5 FDA Drug Approvals to Watch in 2026 https://novapharmanews.com/apac/news/india-vietnam-relations-diplomatic-push 2026-05-28T11:46:04.855Z NovaPharmaNews en-AU 2026-05-28T09:31:55.221Z India Strengthens Vietnam Relations Amid Regional Diplomacy https://novapharmanews.com/uploads/articles/india-vietnam-relations-diplomatic-push.webp India Strengthens Vietnam Relations Amid Regional Diplomacy https://novapharmanews.com/apac/news/premia-lind-lind-asia-ai-clinical-trials 2026-05-28T12:11:49.592Z NovaPharmaNews en-AU 2026-05-28T09:31:55.221Z PREMIA and Lind Launch Lind Asia for AI Clinical Trials https://novapharmanews.com/uploads/articles/premia-lind-lind-asia-ai-clinical-trials.webp PREMIA and Lind Launch Lind Asia for AI Clinical Trials https://novapharmanews.com/apac/news/brenus-pharma-stc-1010-fda-acceptance 2026-05-28T12:27:12.789Z NovaPharmaNews en-AU 2026-05-28T09:31:55.221Z Brenus Pharma's STC-1010 IND Application Accepted by FDA STC-1010, MSS Metastatic Colorectal Cancer, mCRC https://novapharmanews.com/uploads/articles/brenus-pharma-stc-1010-fda-acceptance.webp Brenus Pharma's STC-1010 IND Application Accepted by FDA https://novapharmanews.com/apac/news/leaders-shape-future-healthcare-asgh-2026 2026-05-28T12:35:29.982Z NovaPharmaNews en-AU 2026-05-28T09:31:55.221Z Leaders Shape the Future of Healthcare at ASGH 2026 https://novapharmanews.com/uploads/articles/leaders-shape-future-healthcare-asgh-2026.webp Leaders Shape the Future of Healthcare at ASGH 2026 https://novapharmanews.com/apac/news/immunotherapy-pet-ct-imaging-demand-australia 2026-05-28T11:22:44.247Z NovaPharmaNews en-AU 2026-05-28T09:31:55.221Z Immunotherapy Boom Fuels PET/CT Imaging Demand in Australia oncology https://novapharmanews.com/uploads/articles/immunotherapy-pet-ct-imaging-demand-australia.webp Immunotherapy Boom Fuels PET/CT Imaging Demand in Australia https://novapharmanews.com/us/news/sgs-acquires-keystone-bioanalytical-drug-development 2026-05-28T12:12:14.394Z NovaPharmaNews en-US 2026-05-28T09:31:47.592Z SGS Acquires Keystone Bioanalytical: A Game Changer for Drug Development https://novapharmanews.com/uploads/articles/sgs-acquires-keystone-bioanalytical-drug-development.webp SGS Acquires Keystone Bioanalytical: A Game Changer for Drug Development https://novapharmanews.com/eu/news/europe-boost-clinical-trials 2026-05-28T11:36:33.549Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z Why Europe Must Boost Clinical Trials for Future Growth https://novapharmanews.com/uploads/articles/europe-boost-clinical-trials.webp Why Europe Must Boost Clinical Trials for Future Growth https://novapharmanews.com/eu/news/eu-draft-deal-essential-medicine-shortages 2026-05-28T12:03:36.066Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z EU Draft Deal Addresses Essential Medicine Shortages https://novapharmanews.com/uploads/articles/eu-draft-deal-essential-medicine-shortages.webp EU Draft Deal Addresses Essential Medicine Shortages https://novapharmanews.com/eu/news/fda-real-time-clinical-trials-progress 2026-05-28T12:09:37.688Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z FDA Advances Real-Time Clinical Trials Implementation https://novapharmanews.com/uploads/articles/fda-real-time-clinical-trials-progress.webp FDA Advances Real-Time Clinical Trials Implementation https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-05-28T12:11:50.093Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights oncology, breast cancer https://novapharmanews.com/uploads/articles/hayes-esmo-breast-cancer-award-2026.webp Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights https://novapharmanews.com/eu/news/may-2026-global-health-wash-funding-opportunities 2026-05-28T12:19:49.415Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z May 2026 Global Health & WASH Funding Opportunities https://novapharmanews.com/uploads/articles/may-2026-global-health-wash-funding-opportunities.webp May 2026 Global Health & WASH Funding Opportunities https://novapharmanews.com/eu/news/us-eu-pharmaceutical-regulations-concerns 2026-05-28T12:03:41.404Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z US Raises Concerns Over EU Pharmaceutical Regulations https://novapharmanews.com/uploads/articles/us-eu-pharmaceutical-regulations-concerns.webp US Raises Concerns Over EU Pharmaceutical Regulations https://novapharmanews.com/eu/news/ema-accepts-teva-once-monthly-schizophrenia-shot 2026-05-28T11:10:15.851Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z EMA Accepts Teva's Application for Once-Monthly Schizophrenia Shot schizophrenia https://novapharmanews.com/uploads/articles/ema-accepts-teva-once-monthly-schizophrenia-shot.webp EMA Accepts Teva's Application for Once-Monthly Schizophrenia Shot https://novapharmanews.com/eu/news/malaysia-npra-fda-ema-drug-recognition-pilot 2026-05-28T12:11:27.960Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z Malaysia's NPRA Launches Pilot for FDA and EMA Drug Recognition https://novapharmanews.com/uploads/articles/malaysia-npra-fda-ema-drug-recognition-pilot.webp Malaysia's NPRA Launches Pilot for FDA and EMA Drug Recognition https://novapharmanews.com/eu/news/ema-fda-good-ai-practice-drug-development 2026-05-28T12:50:12.656Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z EMA and FDA Align on Good AI Practice in Drug Development https://novapharmanews.com/uploads/articles/ema-fda-good-ai-practice-drug-development.webp EMA and FDA Align on Good AI Practice in Drug Development https://novapharmanews.com/eu/news/serd-therapy-anti-proliferative-activity-er-her2-breast-cancer 2026-05-28T11:12:33.760Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z SERD Therapy Shows Strong Anti-Proliferative Activity in ER+/HER2- Breast Cancer oncology, breast cancer, ER+ breast cancer, HER2 breast cancer https://novapharmanews.com/uploads/articles/serd-therapy-anti-proliferative-activity-er-her2-breast-cancer.webp SERD Therapy Shows Strong Anti-Proliferative Activity in ER+/HER2- Breast Cancer https://novapharmanews.com/eu/news/key-cancer-drugs-esmo-2025 2026-05-28T12:11:10.820Z NovaPharmaNews en-GB 2026-05-28T09:31:47.592Z Key Cancer Drugs to Watch at ESMO 2025 oncology, cancer https://novapharmanews.com/uploads/articles/key-cancer-drugs-esmo-2025.webp Key Cancer Drugs to Watch at ESMO 2025 https://novapharmanews.com/us/news/fda-declines-guidance-foreign-drug-imports 2026-05-28T12:41:52.419Z NovaPharmaNews en-US 2026-05-28T09:31:47.592Z FDA Declines Guidance on Foreign Drug Imports: Key Regulatory Update https://novapharmanews.com/uploads/articles/fda-declines-guidance-foreign-drug-imports.webp FDA Declines Guidance on Foreign Drug Imports: Key Regulatory Update https://novapharmanews.com/us/news/chinas-licensing-boom-global-pipelines 2026-05-28T11:36:52.255Z NovaPharmaNews en-US 2026-05-28T09:31:47.592Z China’s Licensing Boom: A Shift in Global Pharma Pipelines https://novapharmanews.com/uploads/articles/chinas-licensing-boom-global-pipelines.webp China’s Licensing Boom: A Shift in Global Pharma Pipelines https://novapharmanews.com/apac/news/regulatory-updates-optical-coherence-tomography-pharma 2026-05-28T11:09:30.016Z NovaPharmaNews en-AU 2026-05-28T09:31:47.592Z Regulatory Updates on Optical Coherence Tomography in Pharma https://novapharmanews.com/uploads/articles/regulatory-updates-optical-coherence-tomography-pharma.webp Regulatory Updates on Optical Coherence Tomography in Pharma https://novapharmanews.com/apac/news/blockbuster-drugs-patent-cliff-2026-oncology 2026-05-28T12:40:45.622Z NovaPharmaNews en-AU 2026-05-28T09:31:47.592Z Blockbuster Drugs Face Patent Cliff in 2026: Oncology Insights oncology https://novapharmanews.com/uploads/articles/blockbuster-drugs-patent-cliff-2026-oncology.webp Blockbuster Drugs Face Patent Cliff in 2026: Oncology Insights https://novapharmanews.com/apac/news/nuance-pharma-ind-clearance-actair-china 2026-05-28T12:55:12.877Z NovaPharmaNews en-AU 2026-05-28T09:31:47.592Z Nuance Pharma Secures IND Clearance for Actair® in China Actair, oncology https://novapharmanews.com/uploads/articles/nuance-pharma-ind-clearance-actair-china.webp Nuance Pharma Secures IND Clearance for Actair® in China https://novapharmanews.com/us/news/industry-groups-fda-guidance-form-483 2026-05-28T12:10:24.853Z NovaPharmaNews en-US 2026-05-28T09:31:47.592Z Industry Groups Push for FDA Guidance Changes on Form 483 Responses https://novapharmanews.com/uploads/articles/industry-groups-fda-guidance-form-483.webp Industry Groups Push for FDA Guidance Changes on Form 483 Responses https://novapharmanews.com/us/news/fda-clarifies-3-year-exclusivity-guidance 2026-05-28T11:09:30.221Z NovaPharmaNews en-US 2026-05-28T09:31:47.592Z FDA Clarifies 3-Year Exclusivity Guidance: Key Insights https://novapharmanews.com/uploads/articles/fda-clarifies-3-year-exclusivity-guidance.webp FDA Clarifies 3-Year Exclusivity Guidance: Key Insights https://novapharmanews.com/apac/news/bukwang-pharmaceutical-dreamcis-aws-clinical-trials 2026-05-28T14:17:23.040Z NovaPharmaNews en-AU 2026-05-27T04:39:09.399Z Bukwang Pharmaceutical Partners with DreamCIS and AWS for Clinical Trials https://novapharmanews.com/uploads/articles/bukwang-pharmaceutical-dreamcis-aws-clinical-trials.webp Bukwang Pharmaceutical Partners with DreamCIS and AWS for Clinical Trials https://novapharmanews.com/apac/news/lundbeck-korean-approval-vyepti-oncology-migraine 2026-05-28T12:52:58.979Z NovaPharmaNews en-AU 2026-05-27T04:39:09.399Z Lundbeck Secures Korean Approval for Vyepti: Implications for Oncology and Migraine Treatment Vyepti, oncology, migraine https://novapharmanews.com/uploads/articles/lundbeck-korean-approval-vyepti-oncology-migraine.webp Lundbeck Secures Korean Approval for Vyepti: Implications for Oncology and Migraine Treatment https://novapharmanews.com/eu/news/maat-pharma-q1-2026-business-update 2026-05-28T13:38:29.246Z NovaPharmaNews en-GB 2026-05-27T04:39:09.399Z MaaT Pharma Q1 2026 Business Update and Financial Results https://novapharmanews.com/uploads/articles/maat-pharma-q1-2026-business-update.webp MaaT Pharma Q1 2026 Business Update and Financial Results https://novapharmanews.com/eu/news/critical-medicines-act-impact-pharmaceutical-manufacturing-europe 2026-05-28T12:11:57.961Z NovaPharmaNews en-GB 2026-05-27T04:39:09.399Z The Critical Medicines Act: Transforming Pharma Manufacturing in Europe https://novapharmanews.com/uploads/articles/critical-medicines-act-impact-pharmaceutical-manufacturing-europe.webp The Critical Medicines Act: Transforming Pharma Manufacturing in Europe https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a 2026-05-28T12:11:03.374Z NovaPharmaNews en-GB 2026-05-27T04:39:09.399Z Arrowhead Pharmaceuticals Unveils Positive Cardiometabolic Data at European A cardiometabolic disorders https://novapharmanews.com/uploads/articles/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a.webp Arrowhead Pharmaceuticals Unveils Positive Cardiometabolic Data at European A https://novapharmanews.com/apac/news/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis 2026-05-28T13:58:35.930Z NovaPharmaNews en-AU 2026-05-27T04:39:09.399Z 60 Degrees Pharmaceuticals Initiates Clinical Trial for Tafenoquine in Babesiosis Patients Tafenoquine, Babesiosis https://novapharmanews.com/uploads/articles/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis.webp 60 Degrees Pharmaceuticals Initiates Clinical Trial for Tafenoquine in Babesiosis Patients https://novapharmanews.com/us/news/fda-vs-ema-camizestrant-controversy 2026-05-28T13:27:40.897Z NovaPharmaNews en-US 2026-05-27T04:39:09.399Z FDA vs EMA: The Camizestrant Controversy Camizestrant, oncology https://novapharmanews.com/uploads/articles/fda-vs-ema-camizestrant-controversy.webp FDA vs EMA: The Camizestrant Controversy https://novapharmanews.com/us/news/astellas-xtandi-patent-cliff-strategic-moves 2026-05-28T14:06:11.195Z NovaPharmaNews en-US 2026-05-27T04:39:09.399Z Astellas Faces Xtandi Patent Cliff: Strategic Moves Ahead Xtandi https://novapharmanews.com/uploads/articles/astellas-xtandi-patent-cliff-strategic-moves.webp Astellas Faces Xtandi Patent Cliff: Strategic Moves Ahead https://novapharmanews.com/us/news/best-biotech-stocks-may-2026-clinical-trials 2026-05-28T13:07:36.735Z NovaPharmaNews en-US 2026-05-27T04:39:09.399Z Top Biotech Stocks to Watch in May 2026: Clinical Trials Insights https://novapharmanews.com/uploads/articles/best-biotech-stocks-may-2026-clinical-trials.webp Top Biotech Stocks to Watch in May 2026: Clinical Trials Insights